Increased neutralizing antibody response after simultaneous immunization with leucogen and the feline leukemia virus transmembrane protein

Intervirology

Volumn 54, Issue 2, 2011, Pages 78-86

  Langhammer, Stefan ^a   Fiebig, Uwe ^a   Kurth, Reinhard ^a   Denner, Joachim ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Feline leukemia virus; Neutralizing antibodies; Transmembrane envelope protein; Vaccination

Indexed keywords

ENVELOPE PROTEIN; EPITOPE; FELINE LEUKEMIA VIRUS VACCINE; LEUCOGEN; MEMBRANE PROTEIN; NEUTRALIZING ANTIBODY; PROTEIN P15; RECOMBINANT ENVELOPE PROTEIN 15E; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG TARGETING; EPITOPE MAPPING; FELINE LEUKEMIA VIRUS; IMMUNIZATION; KOALA; MEMBRANE PROXIMAL EXTERNAL REGION; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; RAT; RETROVIRUS; TREATMENT RESPONSE; VACCINATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; EPITOPE MAPPING; IMMUNIZATION; NEUTRALIZATION TESTS; RATS; RATS, WISTAR; RETROVIRIDAE PROTEINS, ONCOGENIC; VIRAL VACCINES;

FELINE LEUKEMIA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; PHASCOLARCTIDAE; PORCINE ENDOGENOUS RETROVIRUS; RATTUS;

EID: 77956390808     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000318892     Document Type: Article

References (28)

1. Arita I: Farewell to smallpox vaccination. Dev Biol Stand 1979; 43: 283-296. (Pubitemid 10250915)
2. McGaughey GB, Citron M, Danzeisen RC, Freidinger RM, Garsky VM, Hurni WM, Joyce JG, Liang X, Miller M, Shiver J, Bogusky MJ: HIV-1 vaccine development: constrained peptide immunogens show improved binding to the anti-HIV-1 gp41 MAb. Biochemistry 2003; 25: 3214-3223. (Pubitemid 36348629)
3. Armbruster C, Stiegler GM, Vcelar BA, Jager W, Koller U, Jilch, R Ammann CG, Pruenster M, Stoiber H, Katinger HW: Passive immunization with the anti-HIV-1 human monoclonal antibody (hMAb) 4E10 and the hMAb combination 4E10/2F5/2G12. J Antimicrob Chemother 2004; 54: 915-920. (Pubitemid 39529987)
4. Muster T, Steindl F, Purtscher M, Trkola A, Klima A, Himmler G, Ruker F, Katinger H: A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J Virol 1993; 67: 6642-6647. (Pubitemid 23309131)
5. Kunert R, Wolbank S, Stiegler G, Weik R, Katinger H: Characterization of molecular features, antigen-binding, and in vitro properties of IgG and IgM variants of 4E10, an anti-HIV type 1 neutralizing monoclonal antibody. AIDS Res Hum Retroviruses 2004; 20: 755-762. (Pubitemid 39037507)
6. McGaughey GB, Barbato G, Bianchi E, Freidinger RM, Garsky VM, Hurni WM, Joyce JG, Liang X, Miller MD, Pessi A, Shiver JW, Bogusky MJ: Progress towards the development of a HIV-1 gp41-directed vaccine. Curr HIV Res 2004; 2: 193-204. (Pubitemid 38854931)
7. Zhang H, Huang Y, Fayad R, Spear GT, Qiao L: Induction of mucosal and systemic neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) by oral immunization with bovine papillomavirus- HIV-1 gp41 chimeric virus-like particles. J Virol 2004; 78: 8342-8348. (Pubitemid 38944318)
8. Jarrett WF: The epidemiology of feline leukemia virus infection. Bibl Haematol 1975; 43: 209-211.
9. Jarrett O, Hardy WD, Golder MC, Hay D: The frequency of occurrence of feline leukemia virus subgroups in cats. Int J Cancer 1978; 21: 334-337. (Pubitemid 8283054)
10. Sparkes AH: Feline leukemia virus: a review of immunity and vaccination. J Small Anim Pract 1997; 38: 187-194. (Pubitemid 127518883)
11. Jarrett O, Ganiere JP: Comparative studies of the efficacy of a recombinant feline leukaemia virus vaccine. Vet Rec 1996; 138: 7-11. (Pubitemid 26018667)
12. Fiebig U, Stephan O, Kurth R, Denner J: Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation? Virology 2003; 307: 406-413. (Pubitemid 36344171)
13. Langhammer S, Fiebig U, Kurth R, Denner J: Neutralising antibodies against the transmembrane protein of feline leukaemia virus (FeLV). Vaccine 2005; 23: 3341-3348. (Pubitemid 40523129)
14. Langhammer S, Hübner J, Kurth R, Denner J: Antibodies neutralising feline leukaemia virus (FeLV) in cats immunised with the transmembrane envelope protein p15E. Immunology 2006; 117: 229-237.
15. Fiebig U, Hartmann MG, Bannert N, Kurth R, Denner J: Transspecies transmission of the endogenous koala retrovirus (KoRV). J Virol 2006; 80: 5651-5654.
16. Follis KE, Larson SJ, Lu M, Nunberg JH: Genetic evidence that interhelical packing interactions in the gp41 core are critical for transition of the human immunodeficiency virus type 1 envelope glycoprotein to the fusion- active state. J Virol 2002; 76: 7356-7362.
17. Hofmann-Lehmann R, Tandon R, Boretti FS, Meli ML, Willi B, Cattori V, Gomes- Keller MA, Ossent P, Golder MC, Flynn JN, Lutz H: Reassessment of feline leukaemia virus (FeLV) vaccines with novel sensitive molecular assays. Vaccine 2006; 24: 1087-1094. (Pubitemid 43202254)
18. Jarrett O: Feline leukaemia virus neutralising antibodies. Vet Rec 2001; 17: 632. (Pubitemid 33094690)
19. Hanlon L, Argyle D, Bain D, Nicolson L, Dunham S, Golder MC, McDonald M, Mc- Gillivray C, Jarrett O, Neil JC, Onions DE: Feline leukemia virus DNA vaccine efficacy is enhanced by coadministration with interleukin- 12 (IL-12) and IL-18 expression vectors. J Virol 2001; 75: 8424-8433. (Pubitemid 32768946)
20. Flynn JN, Hanlon L, Jarrett O: Feline leukaemia virus: protective immunity is mediated by virus-specific cytotoxic T lymphocytes. Immunology 2000; 101: 120-125.
21. Hoover EA, Olsen RG Jr, Hardy WD, Schaller JP: Horizontal transmission of feline leukemia virus under experimental conditions. J Natl Cancer Inst 1977; 58: 443-444. (Pubitemid 8042370)
22. Haley PJ, Hoover EA, Quackenbush SL, Gasper PW, Macy DW: Influence of antibody infusion on pathogenesis of experimental feline leukemia virus infection. J Natl Cancer Inst 1985; 74: 821-827. (Pubitemid 15118240)
23. Osterhaus A, Weijer K, Uytdehaag F, Jarrett O, Sundquist B, Morein B: Induction of protective immune response in cats by vaccination with feline leukemia virus iscom. J Immunol 1985; 135: 591-596. (Pubitemid 15012431)
24. Osterhaus A, Weijer K, UytdeHaag F, Knell P, Jarrett O, Akerblom L, Morein B: Serological responses in cats vaccinated with FeLV ISCOM and an inactivated FeLV vaccine. Vaccine 1989; 7: 137-141. (Pubitemid 19089671)
25. Weijer K, Pfauth A, van Herwijnen R, Jarrett O, Meloen RH, Tomee C, Osterhaus AD: Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene. Vaccine 1993; 11: 946-956. (Pubitemid 23218804)
26. Bechtel MK, Mathes LE, Hayes KA, Phipps AJ, Roy-Burman P: In vivo evolution and selection of recombinant feline leukemia virus species. Virus Res 1998; 54: 71-86.
27. Kleiser C, Schneider J, Bayer H, Hunsmann G: Immunoprevention of Friend leukaemia virus-induced erythroleukaemia by vaccination with aggregated gp70. J Gen Virol 1986; 67: 1901-1907. (Pubitemid 16017274)
28. Thiel HJ, Schwarz H, Fischinger P, Bolognesi D, Schäfer W: Role of antibodies to murine leukemia virus p15E transmembrane protein in immunotherapy against AKR leukemia: a model for studies in human acquired immunodeficiency syndrome. Proc Natl Acad Sci USA 1987; 84: 5893-5897.